Neuropathic pain and motor deficits are detrimental consequences of injury to the spinal cord. In experimental settings, numerous neuroprotective agents are being explored for their therapeutic benefits. Vascular endothelial growth factor (VEGF) is an interesting candidate molecule in this respect since it is not only associated with angiogenesis, but also with neuroprotection and neurite growth. Other investigators have reported improved motor outcomes following intraparenchymal VEGF treatment. Here we demonstrate the therapeutic effects of daily intrathecal treatment of the contused thoracic rat spinal cord with the 165-isoform of VEGF during the first week after injury. We show that VEGF treatment resulted in a statistically significant attenuation of mechanical, but not thermal, hypersensitivity of the hindpaws, while motor deficits remained unaffected. Tissue sparing was also unchanged by VEGF treatment. Microglial responses at the lumbar spinal cord, which have been linked with spinal cord injury–induced hypersensitivity, were found to be unaffected by VEGF treatment. We conclude that repetitive intrathecal VEGF delivery has limited therapeutic effects on spinal cord injury outcome.
Get full access to this article
View all access options for this article.
References
1.
BartholdiD., RubinB.P., SchwabM.E.1997. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci., 9:2549–2560.
2.
BassoD.M., BeattieM.S., BresnahanJ.C.1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma, 12:1–21.
CarltonS.M., DuJ., TanH.Y., NesicO., HargettG.L., BoppA.C., YamaniA., LinQ., WillisW.D., HulseboschC.E.2009. Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury. Pain, 147:265–276.
5.
ChristensenM.D., HulseboschC.E.1997. Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat. Exp. Neurol., 147:463–475.
6.
CitronB.A., ArnoldP.M., HaynesN.G., AmeenuddinS., FarooqueM., SantacruzK., FestoffB.W.2008. Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury. Spine (Phila. Pa. 1976), 33:2269–2277.
7.
DetloffM.R., FisherL.C., McGaughyV., LongbrakeE.E., PopovichP.G., BassoD.M.2008. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp. Neurol., 212:337–347.
8.
DeumensR., JakenR.J., KnaepenL., van der MeulenI., JoostenE.A.2009. Inverse relation between intensity of GFAP expression in the substantia gelatinosa and degree of chronic mechanical allodynia. Neurosci. Lett., 452:101–105.
9.
DeumensR., JakenR.J., MarcusM.A., JoostenE.A.2007a. The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection. J. Neurosci. Methods, 164:120–130.
10.
DeumensR., JoostenE.A., WaxmanS.G., HainsB.C.2008. Locomotor dysfunction and pain: the scylla and charybdis of fiber sprouting after spinal cord injury. Mol. Neurobiol., 37:52–63.
11.
DeumensR., KoopmansG.C., HonigW.M., HamersF.P., MaquetV., JeromeR., SteinbuschH.W., JoostenE.A.2006a. Olfactory ensheathing cells, olfactory nerve fibroblasts and biomatrices to promote long-distance axon regrowth and functional recovery in the dorsally hemisected adult rat spinal cord. Exp. Neurol., 200:89–103.
12.
DeumensR., KoopmansG.C., HonigW.M., MaquetV., JeromeR., SteinbuschH.W., JoostenE.A.2006b. Chronically injured corticospinal axons do not cross large spinal lesion gaps after a multifactorial transplantation strategy using olfactory ensheathing cell/olfactory nerve fibroblast-biomatrix bridges. J. Neurosci. Res., 83:811–820.
13.
DeumensR, KoopmansG.C., HonigW.M., MaquetV., JeromeR., SteinbuschH.W., JoostenE.A.2006c. Limitations in transplantation of astroglia-biomatrix bridges to stimulate corticospinal axon regrowth across large spinal lesion gaps. Neurosci. Lett., 400:208–212.
14.
DeumensR., KoopmansG.C., JoostenE.A.2005. Regeneration of descending axon tracts after spinal cord injury. Prog. Neurobiol., 77:57–89.
DonnellyD.J., PopovichP.G.2008. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol., 209:378–388.
17.
FacchianoF., FernandezE., MancarellaS., MairaG., MiscusiM., D'ArcangeloD., Cimino-RealeG., FalchettiM.L., CapogrossiM.C., PalliniR.2002. Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J. Neurosurg., 97:161–168.
18.
FaulknerJ.R., HerrmannJ.E., WooM.J., TanseyK.E., DoanN.B., SofroniewM.V.2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci., 24:2143–2155.
19.
FelixE.R., Cruz-AlmeidaY., Widerstrom-NogaE.G.2007. Chronic pain after spinal cord injury: What characteristics make some pains more disturbing than others? J. Rehabil. Res. Dev., 44:703–716.
20.
GrisD., MarshD.R., OatwayM.A., ChenY., HamiltonE.F., DekabanG.A., WeaverL.C.2004. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J. Neurosci., 24:4043–4051.
21.
GwakY.S., HulseboschC.E.2009. Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat. Neuroscience, 161:895–903.
22.
HainsB.C., WaxmanS.G.2006. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci., 26:4308–4317.
23.
HainsB.C., YucraJ.A., HulseboschC.E.2001. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J. Neurotrauma, 18:409–423.
24.
HamersF.P., KoopmansG.C., JoostenE.A.2006. CatWalk-assisted gait analysis in the assessment of spinal cord injury. J. Neurotrauma, 23:537–548.
25.
HamersF.P., LankhorstA.J., van LaarT.J., VeldhuisW.B., GispenW.H.2001. Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J. Neurotrauma, 18:187–201.
26.
HargreavesK., DubnerR., BrownF., FloresC., JorisJ.1988. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32:77–88.
27.
HerreraJ.J., Nesic-TaylorD.O., NarayanaP.A.2009. Reduced vascular endothelial growth factor expression in contusive spinal cord injury. J. Neurotrauma, 26:995–1003.
HulseboschC.E.2008. Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp. Neurol., 214:6–9.
30.
HulseboschC.E., HainsB.C., CrownE.D., CarltonS.M.2009. Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res. Rev., 60:202–213.
31.
JiR.R., KawasakiY., ZhuangZ.Y., WenY.R., DecosterdI.2006. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol., 2:259–269.
32.
JonesT.B., McDanielE.E., PopovichP.G.2005. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des., 11:1223–1236.
33.
KloosA.D., FisherL.C., DetloffM.R., HassenzahlD.L., BassoD.M.2005. Stepwise motor and all-or-none sensory recovery is associated with nonlinear sparing after incremental spinal cord injury in rats. Exp. Neurol., 191:251–265.
34.
KoopmansG.C., BransM., Gomez-PinillaF., DuisS., GispenW.H., Torres-AlemanI., JoostenE.A., HamersF.P.2006. Circulating insulin-like growth factor I and functional recovery from spinal cord injury under enriched housing conditions. Eur. J. Neurosci., 23:1035–1046.
35.
KoopmansG.C., DeumensR., BrookG., GerverJ., HonigW.M., HamersF.P., JoostenE.A.2007. Strain and locomotor speed affect over-ground locomotion in intact rats. Physiol. Behav., 92:993–1001.
KoopmansG.C., DeumensR., HonigW.M., HamersF.P., SteinbuschH.W., JoostenE.A.2005. The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination. J. Neurotrauma, 22:214–225.
38.
KrumJ.M., ManiN., RosensteinJ.M.2002. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience, 110:589–604.
39.
KrumJ.M., RosensteinJ.M.1998. VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp. Neurol., 154:57–65.
40.
LiM., OnaV.O., ChenM., KaulM., TennetiL., ZhangX., StiegP.E., LiptonS.A., FriedlanderR.M.2000. Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury. Neuroscience, 99:333–342.
41.
LiuY., FigleyS., SprattS.K., LeeG., AndoD., SuroskyR., FehlingsM.G.2010. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiol. Dis., 37:384–393.
42.
MineurP., ColigeA.C., DeroanneC.F., DubailJ., KestelootF., HabrakenY., NoelA., VooS., WaltenbergerJ., LapiereC.M., NusgensB.V., LambertC.A.2007. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. J. Cell Biol., 179:1261–1273.
43.
MoalemG., Leibowitz-AmitR., YolesE., MorF., CohenI.R., SchwartzM.1999. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med., 5:49–55.
44.
NepomucenoC., FineP.R., RichardsJ.S., GowensH., StoverS.L., RantanuabolU., HoustonR.1979. Pain in patients with spinal cord injury. Arch. Phys. Med. Rehabil., 60:605–609.
45.
NesicO., LeeJ., JohnsonK.M., YeZ., XuG.Y., UnabiaG.C., WoodT.G., McAdooD.J., WestlundK.N., HulseboschC.E., Regino Perez-PoloJ.2005. Transcriptional profiling of spinal cord injury-induced central neuropathic pain. J. Neurochem., 95:998–1014.
46.
ParkS.W., YiJ.H., MiranpuriG., SatriotomoI., BowenK., ResnickD.K., VemugantiR.2007. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J. Pharmacol. Exp. Ther., 320:1002–1012.
47.
PatelC.B., CohenD.M., Ahobila-VajjulaP., SundbergL.M., ChackoT., NarayanaP.A.2009. Effect of VEGF treatment on blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging. J. Neurotrauma, 26:1005–1016.
48.
PlunkettJ.A., YuC.G., EastonJ.M., BetheaJ.R., YezierskiR.P.2001. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol., 168:144–154.
RosensteinJ.M., KrumJ.M.2004. New roles for VEGF in nervous tissue—beyond blood vessels. Exp. Neurol., 187:246–253.
51.
SchwartzM., MoalemG., Leibowitz-AmitR., CohenI.R.1999. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci., 22:295–299.
52.
SiddallP.J., McClellandJ.M., RutkowskiS.B., CousinsM.J.2003. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain, 103:249–257.
53.
SkoldM., CullheimS., HammarbergH., PiehlF., SunesonA., LakeS., SjogrenA., WalumE., RislingM.2000. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur. J. Neurosci., 12:3675–3686.
54.
SofroniewM.V.2005. Reactive astrocytes in neural repair and protection. Neuroscientist, 11:400–407.
55.
SondellM., LundborgG., KanjeM.1999. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci., 19:5731–5740.
56.
TangaF.Y., RaghavendraV., Nutile-McMenemyN., MarksA., DeleoJ.A.2006. Role of astrocytic S100beta in behavioral hypersensitivity in rodent models of neuropathic pain. Neuroscience, 140:1003–1010.
57.
VaqueroJ., ZuritaM., de OyaS., CocaS.1999. Vascular endothelial growth/permeability factor in spinal cord injury. J. Neurosurg., 90:220–223.
ZhaoP., WaxmanS.G., HainsB.C.2007a. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci., 27:2357–2368.
60.
ZhaoP., WaxmanS.G., HainsB.C.2007b. Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci., 27:8893–8902.
